FDA Sees 2012 Budget Buoyed by Fees

The Food and Drug Administration plans several new initiatives in regulatory science, patient protection, medical countermeasures, and food safety.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register quickly here for free access.